Metabolic and molecular relative percentage coreduction in patients with locally advanced rectal cancer treated with neoadjuvant therapy

Purpose Vascular endothelial growth factor receptor-2 (VEGFR-2), epidermal growth factor receptor-1 (EGFR) and cyclooxygenase-2 (COX-2) stimulate key processes involved in tumour progression and are important targets for cancer therapeutics. 18 F-FDG maximum standardized uptake value (SUVmax) on PET...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European journal of nuclear medicine and molecular imaging 2016-07, Vol.43 (8), p.1444-1452
Hauptverfasser:	Sole, Claudio V., Calvo, Felipe A., Alvarez, Emilio, Carreras, Jose L.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Cardiology Chemotherapy Clinical outcomes Colorectal cancer Cyclooxygenase 2 - metabolism Disease-Free Survival Female Humans Imaging Male Medical imaging Medicine Medicine & Public Health Middle Aged Neoadjuvant Therapy Nuclear Medicine Oncology Original Article Orthopedics Positron Emission Tomography Computed Tomography Radiation therapy Radiology Receptor, Epidermal Growth Factor - metabolism Rectal Neoplasms - metabolism Rectal Neoplasms - pathology Rectal Neoplasms - therapy Tomography Treatment Outcome Vascular Endothelial Growth Factor Receptor-2 - metabolism
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!